Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel

NCT01147588 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

149

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: lansoprazole
DRUG: omeprazole
DRUG: esomeprazole
DRUG: clopidogrel

Sponsor

AstraZeneca